NYSE:STE - Steris Stock Price, Forecast & News

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Steris announced a quarterly dividend on Monday, February 10th. Stockholders of record on Tuesday, February 25th will be given a dividend of $0.37 per share on Thursday, March 26th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 0.88%. The ex-dividend date of this dividend is Monday, February 24th. View Steris' Dividend History.

Steris PLC (NYSE:STE) released its earnings results on Monday, February, 10th. The medical equipment provider reported $1.45 EPS for the quarter, topping the consensus estimate of $1.42 by $0.03. The medical equipment provider earned $774.30 million during the quarter, compared to the consensus estimate of $748.45 million. Steris had a return on equity of 16.33% and a net margin of 13.21%. The firm's quarterly revenue was up 11.2% on a year-over-year basis. During the same period last year, the firm posted $1.26 EPS. View Steris' Earnings History.

Steris is scheduled to release their next quarterly earnings announcement on Monday, May 11th 2020. View Earnings Estimates for Steris.

Steris issued an update on its FY 2020 After-Hours earnings guidance on Monday, February, 10th. The company provided EPS guidance of 5.65-5.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.57.

4 brokers have issued 12 month price objectives for Steris' stock. Their forecasts range from $138.00 to $177.00. On average, they anticipate Steris' stock price to reach $155.00 in the next year. This suggests that the stock has a possible downside of 8.0%. View Analyst Price Targets for Steris.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Steris.

Media coverage about STE stock has trended very negative on Tuesday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Steris earned a news impact score of -3.0 on InfoTrie's scale. They also gave news stories about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Steris.

Steris saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 2,030,000 shares, an increase of 42.0% from the January 15th total of 1,430,000 shares. Based on an average daily volume of 698,500 shares, the days-to-cover ratio is presently 2.9 days. Currently, 2.4% of the company's stock are sold short. View Steris' Current Options Chain.

Some companies that are related to Steris include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Mastercard (MA), Gilead Sciences (GILD), AbbVie (ABBV), Mcdonald's (MCD), Pfizer (PFE), Stryker (SYK), Abbott Laboratories (ABT), Allergan (AGN) and AT&T (T).

Steris' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (4.23%), WCM Investment Management LLC (2.76%), Massachusetts Financial Services Co. MA (2.30%), William Blair Investment Management LLC (1.26%), Goldman Sachs Group Inc. (1.24%) and FMR LLC (1.23%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for Steris.

STE stock was sold by a variety of institutional investors in the last quarter, including Great West Life Assurance Co. Can, Principal Financial Group Inc., WCM Investment Management LLC, Bank of New York Mellon Corp, Renaissance Technologies LLC, American International Group Inc., FMR LLC and First Trust Advisors LP. Company insiders that have sold Steris company stock in the last year include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves and Walter M Rosebrough Jr. View Insider Buying and Selling for Steris.

STE stock was bought by a variety of institutional investors in the last quarter, including Pictet Asset Management Ltd., State Street Corp, Goldman Sachs Group Inc., Massachusetts Financial Services Co. MA, Franklin Resources Inc., Charles Schwab Investment Management Inc., ArrowMark Colorado Holdings LLC and Barclays PLC. View Insider Buying and Selling for Steris.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of STE stock can currently be purchased for approximately $168.51.

Steris has a market capitalization of $14.29 billion and generates $2.78 billion in revenue each year. The medical equipment provider earns $304.05 million in net income (profit) each year or $4.89 on an earnings per share basis. Steris employs 12,000 workers across the globe.View Additional Information About Steris.

The official website for Steris is http://www.steris.com/.

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]